|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-03
|
$732,311
|
$14,646
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
5R01CA193321-02
|
$362,569
|
$362,569
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$2,360
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$3,418
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$9,999
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$2,684
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
3R01CA176001-03S1
|
$48,411
|
$48,411
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
5R01CA176001-03
|
$323,700
|
$323,700
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$17,478
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
|
5U19CA021239-37
|
$1,912,533
|
$191,253
|
HONG, THEODORE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Genetics of Melanoma
|
5K24CA149202-07
|
$172,041
|
$56,774
|
TSAO, HENSIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Structural Biology of GTPase Activating Proteins
|
ZIA BC 011419
|
$383,366
|
$383,366
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$198,789
|
$17,891
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$469,706
|
$23,485
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$469,706
|
$46,971
|
Daar, Ira
|
CCR (NCI)
|
|
Immunotherapy Strategies for Uveal Melanoma
|
ZIA BC 010649
|
$418,046
|
$292,632
|
Kammula, Udai
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$7,069
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,020,805
|
$204,161
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,435
|
$25,772
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,030,869
|
$51,543
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$580,304
|
$11,606
|
Linet, Martha
|
DCEG (NCI)
|
|
Flow Cytometric Detection of Malignant Cells in Body Fluids
|
ZIC BC 011093
|
$159,113
|
$15,911
|
Stetler-Stevenson, Maryalice
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$497,160
|
$24,858
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Retinoblastoma family study
|
ZIA CP004410-08277
|
$2,488
|
$1,244
|
Tucker, Margaret
|
DCEG (NCI)
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$897,428
|
$44,871
|
Westlake, Christopher
|
CCR (NCI)
|
|
Hereditary cancer predisposition syndromes and uveal melanoma
|
5R21CA191943-02
|
$167,475
|
$167,475
|
ABDEL-RAHMAN, MOHAMED
|
OHIO STATE UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-17S1
|
$117,000
|
$1,170
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
4P30CA056036-17
|
$2,807,751
|
$28,078
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Genome-edited uveal melanoma cell lines for investigating constitutively active GNAQ and GNA11
|
1R03CA202316-01
|
$78,000
|
$78,000
|
WEDEGAERTNER, PHILIP
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-18S1
|
$121,856
|
$1,219
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S2
|
$155,534
|
$1,555
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S3
|
$60,000
|
$600
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S4
|
$80,100
|
$801
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S5
|
$200,000
|
$2,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S6
|
$152,100
|
$1,521
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S7
|
$200,000
|
$2,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
$7,492
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
$70,637
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The GNAQ pathway as a therapeutic target in uveal melanoma
|
2R01CA142873-07
|
$306,698
|
$306,698
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma
|
5R21CA181935-02
|
$174,000
|
$174,000
|
GANGULY, ARUPA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
1R21CA208609-01
|
$203,580
|
$203,580
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
3P30CA042014-27S1
|
$16,667
|
$333
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S2
|
$46,556
|
$931
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S3
|
$33,760
|
$675
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S4
|
$119,533
|
$2,391
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S5
|
$59,998
|
$1,200
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
Total relevant funding to Eye for this search: $4,986,202
|